The cAMP/Epac1/Rap1 Pathway in Pancreatic Carcinoma
Authors:
- 1 July 2008
- journal article
- letter
- Published by Wolters Kluwer Health in Pancreas
- Vol. 37 (1) , 102-103
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Rap1: a key regulator in cell-cell junction formationJournal of Cell Science, 2007
- Epac proteins: multi-purpose cAMP targetsTrends in Biochemical Sciences, 2006
- Rap1-Mediated Activation of Extracellular Signal-Regulated Kinases by Cyclic AMP Is Dependent on the Mode of Rap1 ActivationMolecular and Cellular Biology, 2006
- γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 PathwayCancer Research, 2005
- Mechanism of the spatio‐temporal regulation of Ras and Rap1The EMBO Journal, 2003
- Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptorJournal of Cell Biology, 2003
- A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERKNature Cell Biology, 2002
- Cyclic nucleotide analogs as biochemical tools and prospective drugsPharmacology & Therapeutics, 2000
- 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factorBritish Journal of Cancer, 1999
- cAMP antagonizes p21ras‐directed activation of extracellular signal‐regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.The EMBO Journal, 1993